Open AccessClinical Validation of PBRM1 Alterations as a Marker of Immune Checkpoint Inhibitor Response in Renal Cell Carcinoma
Jama OncologyPeer ReviewedDavid A. Braun +62019Journals
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support